Amelioration of Glucose Intolerance by the Synthetic Androstene HE3286: Link to Inflammatory Pathways
暂无分享,去创建一个
J. Olefsky | C. Ahlem | Min Lu | J. Frincke | C. Reading | S. Villegas | J. Flores-Riveros | S. White | Yujin Huang | D. Alleva | Tianlun Wang
[1] J. Frincke,et al. 7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases. , 2009, Autoimmunity reviews.
[2] J. Olefsky,et al. Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.
[3] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[4] A. Goldfine,et al. Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes , 2008, Clinical and translational science.
[5] M. Karin,et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.
[6] A. Hevener,et al. Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes , 2007, Expert opinion on therapeutic targets.
[7] C. Glass,et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. , 2007, The Journal of clinical investigation.
[8] Laura Herrero,et al. Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.
[9] Y. Tamura,et al. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice , 2006, Diabetologia.
[10] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[11] Claudio Cobelli,et al. DHEA in elderly women and DHEA or testosterone in elderly men. , 2006, The New England journal of medicine.
[12] S. Akira,et al. Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.
[13] R. Kitazawa,et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.
[14] R. Leibel,et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.
[15] P. Scherle,et al. Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344 , 2005, The Journal of Immunology.
[16] S. B. Pedersen,et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.
[17] A. Hevener,et al. IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.
[18] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[19] I. Charo,et al. Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.
[20] L Earl Gray,et al. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[21] G. Muscat,et al. RORalpha regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. , 2004, The Journal of biological chemistry.
[22] G. Muscat,et al. RORα Regulates the Expression of Genes Involved in Lipid Homeostasis in Skeletal Muscle Cells , 2004, Journal of Biological Chemistry.
[23] Xiaohui S. Xie,et al. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle , 2004 .
[24] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[25] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[26] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Glass,et al. PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[29] L. Gray,et al. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[30] H. Lardy,et al. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[31] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[32] Michael Karin,et al. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.
[33] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[34] J. Mariani,et al. The orphan nuclear receptor RORα is a negative regulator of the inflammatory response , 2001 .
[35] D. Brenner,et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.
[36] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[37] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[38] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[39] C. Longcope,et al. Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: relationship to antihyperglycemic effects. , 1987, Metabolism: clinical and experimental.
[40] D. Coleman,et al. Effect of Genetic Background on the Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetes-Obesity Mutants and in Aged Normal Mice , 1984, Diabetes.
[41] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.
[42] Xiaohui Xie,et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] Alimuddin Zumla,et al. Validation of housekeeping genes for normalizing RNA expression in real-time PCR , 2004 .
[44] J. Mariani,et al. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. , 2001, EMBO reports.